|Articles|September 16, 2009
- Fall 2009
- Volume 8
- Issue 3
CYP2D6 Inhibitors
Advertisement
>
Strong CYP2D6 Inhibitors* Paxil (paroxetine)
>
Prozac (fluoxetine)
>
Wellbutrin (bupropion)
>
Moderate CYP2D6 Inhibitors Cymbalta (duloxetine)
>
Zoloft (sertraline)
>
Weak CYP2D6 Inhibitors Celexa (citalopram)
>
Effexor (venlafaxine)
>
Lexapro (escitalopram)
Source: Abbreviated listing from Handbook of Essential Psychopharmacology, second edition, 2005
*To be avoided with tamoxifen
Articles in this issue
almost 17 years ago
Web Exclusive: Quiz: Do You Know the Recommended Screening Guidelines?almost 17 years ago
Web Exclusive: When is Multidisciplinary Care Really Needed?almost 17 years ago
The Internal Flamealmost 17 years ago
Message from the Editoralmost 17 years ago
Letters from Our Readersalmost 17 years ago
Overheatedalmost 17 years ago
I Laughedalmost 17 years ago
Kidney Cancer & Lung Canceralmost 17 years ago
Cancer Screeningalmost 17 years ago
Life Preserver?Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Oncologist Explains What the Rasonque Approval Means for Patients With Metastatic Pancreatic Cancer
2
Prostate Cancer Patients Got the Same Result in Fewer Visits
3
Chemoradiotherapy Preserves the Rectum in 78.5% of Patients at 1 Year
4
What Do Genetics Have to Do With Lung Cancer Risk? Researchers Are Working to Find Out
5